BRPI0413057B8 - compostos e processo para preparação de imipenem - Google Patents

compostos e processo para preparação de imipenem

Info

Publication number
BRPI0413057B8
BRPI0413057B8 BRPI0413057A BRPI0413057A BRPI0413057B8 BR PI0413057 B8 BRPI0413057 B8 BR PI0413057B8 BR PI0413057 A BRPI0413057 A BR PI0413057A BR PI0413057 A BRPI0413057 A BR PI0413057A BR PI0413057 B8 BRPI0413057 B8 BR PI0413057B8
Authority
BR
Brazil
Prior art keywords
compounds
preparing
formula
imipenem
preparing imipenem
Prior art date
Application number
BRPI0413057A
Other languages
English (en)
Inventor
Yong Ahn Chan
Hoon Oh Chang
Seop Bae Hyun
Sung Kim Moo
Seop Hwang Tae
Original Assignee
Choongwae Pharma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Choongwae Pharma Corp filed Critical Choongwae Pharma Corp
Publication of BRPI0413057A publication Critical patent/BRPI0413057A/pt
Publication of BRPI0413057B1 publication Critical patent/BRPI0413057B1/pt
Publication of BRPI0413057B8 publication Critical patent/BRPI0413057B8/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/02—Preparation
    • C07D477/06—Preparation from compounds already containing the ring or condensed ring systems, e.g. by dehydrogenation of the ring, by introduction, elimination or modification of substituents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

"processo para preparação de imipenem". descrito aqui é um composto da fórmula ii abaixo: oh onde r~ 1~ é um grupo de p-nitrobenzila ou p-metoxibenzila; e r~ 2~ e r~ 3~ podem ser idênticos a ou diferentes de cada outro e são cada um independentemente um grupo de arila ou alquila c~ 1-6~, ou um destes derivado, e um processo para preparação do composto da fórmula ii. também descrito é um processo para a preparação de imipenem da fórmula i abaixo: empregando-se o composto da fórmula ii.
BRPI0413057A 2003-12-09 2004-12-09 compostos e processo para preparação de imipenem BRPI0413057B8 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR10-2003-0088857 2003-12-09
KR20030088857 2003-12-09
PCT/KR2004/003224 WO2005056553A1 (en) 2003-12-09 2004-12-09 A new process for preparation of imipenem

Publications (3)

Publication Number Publication Date
BRPI0413057A BRPI0413057A (pt) 2006-10-17
BRPI0413057B1 BRPI0413057B1 (pt) 2018-02-06
BRPI0413057B8 true BRPI0413057B8 (pt) 2021-05-25

Family

ID=36642326

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0413057A BRPI0413057B8 (pt) 2003-12-09 2004-12-09 compostos e processo para preparação de imipenem

Country Status (14)

Country Link
US (1) US7507814B2 (pt)
EP (1) EP1692135A4 (pt)
JP (1) JP4500814B2 (pt)
KR (1) KR100667373B1 (pt)
CN (1) CN100383142C (pt)
AU (1) AU2004296261B2 (pt)
BR (1) BRPI0413057B8 (pt)
CA (1) CA2531578C (pt)
MX (1) MXPA06001115A (pt)
NO (1) NO20062602L (pt)
NZ (1) NZ547641A (pt)
RU (1) RU2314308C2 (pt)
WO (1) WO2005056553A1 (pt)
ZA (1) ZA200604446B (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2328117T3 (es) * 2001-05-18 2009-11-10 Ranbaxy Laboratories Limited Proceso para la preparacion de imipenem.
AU2004296261B2 (en) * 2003-12-09 2007-08-23 Choongwae Pharm. Co. A new process for preparation of imipenem
CN102690266B (zh) * 2011-09-02 2014-06-18 深圳市海滨制药有限公司 一种制备厄他培南钠的方法
CN108623598A (zh) * 2018-05-21 2018-10-09 重庆天地药业有限责任公司 一种亚胺培南中间体及亚胺培南的制备方法
CN115932077B (zh) * 2022-11-15 2025-06-10 泊诺(天津)创新医药研究有限公司 一种培南类抗生素药物杂质聚合物的鉴别及含量测定方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4235920A (en) * 1975-11-21 1980-11-25 Merck & Co., Inc. N-Alkylated derivatives of thienamycin
DK523676A (da) * 1975-11-21 1977-05-22 Merck & Co Inc Fremgangsmade til fremstilling af n-alkylerede derivater af thienamycin
US4172144A (en) * 1976-10-18 1979-10-23 Merck & Co., Inc. Schiff's base derivatives of thienamycin
US4150145A (en) * 1977-09-15 1979-04-17 Merck & Co., Inc. N-alkylated derivatives of thienamycin sulfoxide and sulfone
US4292436A (en) 1980-06-25 1981-09-29 Merck & Co., Inc. Process for the preparation of N-protected N-formimidoyl 2-aminoethanethiol
US4845261A (en) 1987-05-11 1989-07-04 Merck & Co., Inc. Process for bis(substituted phenyl) phosphorohalidates
US4894450A (en) * 1987-05-11 1990-01-16 Merck & Co., Inc. Process for 2-(aminoalkylthio) carbapenems
RU2162088C2 (ru) * 1996-04-26 2001-01-20 Санкио Компани Лимитед 1-метилкарбапенем или его фармакологически приемлемые соли, композиция, способ предупреждения или лечения бактериальных инфекций
IN191798B (pt) 2000-11-03 2004-01-03 Ranbaxy Lab Ltd
ITMI20010077A1 (it) * 2001-01-17 2002-07-18 Acs Dobfar Spa Procedimento per la produzione dell'imipenem
ES2328117T3 (es) * 2001-05-18 2009-11-10 Ranbaxy Laboratories Limited Proceso para la preparacion de imipenem.
AU2004296261B2 (en) * 2003-12-09 2007-08-23 Choongwae Pharm. Co. A new process for preparation of imipenem

Also Published As

Publication number Publication date
RU2006102664A (ru) 2006-08-10
ZA200604446B (en) 2007-10-31
JP4500814B2 (ja) 2010-07-14
WO2005056553A1 (en) 2005-06-23
NZ547641A (en) 2009-02-28
EP1692135A4 (en) 2009-02-25
CA2531578C (en) 2008-10-07
MXPA06001115A (es) 2006-04-11
CN1829716A (zh) 2006-09-06
US7507814B2 (en) 2009-03-24
JP2007501838A (ja) 2007-02-01
BRPI0413057A (pt) 2006-10-17
RU2314308C2 (ru) 2008-01-10
EP1692135A1 (en) 2006-08-23
BRPI0413057B1 (pt) 2018-02-06
NO20062602L (no) 2006-08-31
CA2531578A1 (en) 2005-06-23
KR20050056161A (ko) 2005-06-14
KR100667373B1 (ko) 2007-01-10
CN100383142C (zh) 2008-04-23
AU2004296261B2 (en) 2007-08-23
US20060167243A1 (en) 2006-07-27
AU2004296261A1 (en) 2005-06-23

Similar Documents

Publication Publication Date Title
BR0014133A (pt) Uso de um composto, composto, métodos de preparação de um composto, e para inibir aurora 2 quinase em um animal de sangue quente, e, composição farmacêutica
MXPA04001016A (es) Derivados de sulfonamida como inhibidores de la gamma secretasa.
BRPI0412347A (pt) 2-aminofenil-4-fenilpiridinas como inibidores de quinase
GB0129476D0 (en) Organic compounds
BG101422A (bg) Бензоксазолни производни като бронхоразширяващи средства
BR0207278A (pt) Derivados de ftalazinona-piperidina como inibidores de pde4
WO2004084812A3 (en) Tamandarin analogs and fragments thereof and methods of making and using
TW200510317A (en) Caspase inhibitors and uses thereof
CA2354774A1 (en) Farnesyl protein transferase inhibitors
BR0207846A (pt) Derivados heterocìclicos para o tratamento de câncer e outras doenças proliferativas
IL183373A0 (en) 3-[2-(3-acylamino-2-oxo-2h-pyridin-1-yl)-acetylamino]-4-oxo-pentanoic acid derivatives, pharmaceutical compositions containing the same and methods for the preparation thereof
NO20035553D0 (no) Imidazol-derivater for modulering av natrium-kanaler
BRPI0407282A (pt) Processo para preparação de inibidores de pirrolotriazina cinase
BR9814055A (pt) Composto, composição farmacêutica, processo para o tratamento de uma doença alérgica, uso do composto, e, processos para preparar e para produzir um composto
BR9912575A (pt) Processo para a preparação de um composto, e, composto.
ATE238981T1 (de) Antitumorwirkstoffe
ATE380816T1 (de) Substituierte imidazopyrimidine zur prävention und behandlung von krebs
BR0114277A (pt) Processo para a preparação de compostos de n-(fenil substituìda)-3-alquil-,aril-e heteroarilsulfonil-2-hidróxi-2-alquil-e-haloalquilp ropanamida
BR0308419A (pt) Derivados de azetidina como antagonistas do receptor ccr-3
MY138466A (en) Aminoalkoxyndoles as 5-ht6-receptor ligands for the treatment of cns-disorders
BR0212982A (pt) Processo para preparar um composto, e, composto
BR0113259A (pt) Processo para a preparação de um composto, composto e processo para a preparação de compostos
BRPI0413057A (pt) processo para preparação de imipenem
BR0004823A (pt) Compostos policìclicos de azaindol, processo para a preparação dos mesmos e composições farmacêuticas contendo os mesmos
WO2004075858A3 (en) Flavone acetic acid analogs and methods of use thereof

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: PARA: INT. CL. C07D 477/20; A61P 31/04

Ipc: C07D 477/20 (2011.01), A61P 31/04 (2011.01)

B08E Application fees: payment of additional fee required [chapter 8.5 patent gazette]

Free format text: COMPLEMENTAR 8A. ANUIDADE(S) DE ACORDO COM TABELA VIGENTE REFERENTE A(S) GUIA(S) 921201590808

B08H Application fees: decision cancelled [chapter 8.8 patent gazette]

Free format text: REFERENTE AO DESPACHO PUBLICADO NA RPI 2308 DE 31/03/2015.

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]
B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 09/12/2004 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF